Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,384,833
-$876,204 QoQ
Shares Held
525,620
-30.3% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. VCEL ranks #108 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,384,833 | 525,620 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,261,037 | 754,151 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,902,983 | 497,167 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $6,698,766 | 212,862 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,288,674 | 241,802 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,575,704 | 371,486 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $17,963,970 | 327,153 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,500,869 | 201,204 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,040,836 | 153,462 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,110,451 | 194,357 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,814,863 | 472,195 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $16,189,287 | 482,974 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $9,965,178 | 265,243 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $8,117,328 | 276,853 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,998,119 | 189,754 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $5,017,464 | 216,270 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $5,586,636 | 221,868 | Shares | Defined | 2022-08-18 | |
| 2022-03-31 | $7,807,389 | 204,275 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,583,602 | 192,967 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $12,609,188 | 258,385 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $11,321,152 | 215,641 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $21,747,102 | 391,487 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $25,203,206 | 816,166 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,870,046 | 802,485 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,264,685 | 308,588 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,284,989 | 249,181 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||